<bill session="119" type="h" number="1518" updated="2025-11-05T09:05:33Z">
  <state datetime="2025-02-24">REFERRED</state>
  <status>
    <introduced datetime="2025-02-24"/>
  </status>
  <introduced datetime="2025-02-24"/>
  <titles>
    <title type="display">New Era of Preventing End-Stage Kidney Disease Act</title>
    <title type="short" as="introduced">New Era of Preventing End-Stage Kidney Disease Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act with respect to preventing end-stage kidney disease, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001257"/>
  <cosponsors>
    <cosponsor bioguide_id="B001306" joined="2025-02-24"/>
    <cosponsor bioguide_id="B000490" joined="2025-07-25"/>
    <cosponsor bioguide_id="B001285" joined="2025-05-19"/>
    <cosponsor bioguide_id="C001126" joined="2025-10-21"/>
    <cosponsor bioguide_id="C001066" joined="2025-06-03"/>
    <cosponsor bioguide_id="C001110" joined="2025-07-29"/>
    <cosponsor bioguide_id="C001120" joined="2025-03-14"/>
    <cosponsor bioguide_id="C001121" joined="2025-08-05"/>
    <cosponsor bioguide_id="C001063" joined="2025-11-04"/>
    <cosponsor bioguide_id="D000096" joined="2025-02-24"/>
    <cosponsor bioguide_id="D000230" joined="2025-06-06"/>
    <cosponsor bioguide_id="D000628" joined="2025-03-10"/>
    <cosponsor bioguide_id="F000466" joined="2025-03-11"/>
    <cosponsor bioguide_id="F000474" joined="2025-11-04"/>
    <cosponsor bioguide_id="G000597" joined="2025-07-25"/>
    <cosponsor bioguide_id="G000553" joined="2025-08-12"/>
    <cosponsor bioguide_id="I000058" joined="2025-09-30"/>
    <cosponsor bioguide_id="J000309" joined="2025-08-01"/>
    <cosponsor bioguide_id="J000288" joined="2025-07-23"/>
    <cosponsor bioguide_id="K000397" joined="2025-09-03"/>
    <cosponsor bioguide_id="L000599" joined="2025-05-19"/>
    <cosponsor bioguide_id="L000582" joined="2025-03-03"/>
    <cosponsor bioguide_id="L000397" joined="2025-08-12"/>
    <cosponsor bioguide_id="M001238" joined="2025-08-26"/>
    <cosponsor bioguide_id="M000312" joined="2025-07-29"/>
    <cosponsor bioguide_id="M001226" joined="2025-08-19"/>
    <cosponsor bioguide_id="M001205" joined="2025-02-24"/>
    <cosponsor bioguide_id="N000002" joined="2025-07-25"/>
    <cosponsor bioguide_id="N000147" joined="2025-05-07"/>
    <cosponsor bioguide_id="O000019" joined="2025-05-19"/>
    <cosponsor bioguide_id="O000172" joined="2025-09-03"/>
    <cosponsor bioguide_id="P000608" joined="2025-02-24"/>
    <cosponsor bioguide_id="R000305" joined="2025-08-12"/>
    <cosponsor bioguide_id="R000579" joined="2025-07-23"/>
    <cosponsor bioguide_id="S001190" joined="2025-02-24"/>
    <cosponsor bioguide_id="S001185" joined="2025-02-24"/>
    <cosponsor bioguide_id="S001200" joined="2025-08-12"/>
    <cosponsor bioguide_id="S001215" joined="2025-10-21"/>
    <cosponsor bioguide_id="S001201" joined="2025-05-14"/>
    <cosponsor bioguide_id="T000481" joined="2025-06-30"/>
    <cosponsor bioguide_id="T000469" joined="2025-02-24"/>
    <cosponsor bioguide_id="V000133" joined="2025-09-30"/>
    <cosponsor bioguide_id="V000138" joined="2025-09-03"/>
    <cosponsor bioguide_id="W000795" joined="2025-06-23"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-24">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-24" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2025-02-24">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Genetics"/>
    <term name="Government studies and investigations"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2025-08-13T19:31:48Z" status="Introduced in House">New Era of Preventing End-Stage Kidney Disease Act

This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.

Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.&#160;

The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations.

Also, the bill expands the priorities of&#160;HRSA&#226;&#8364;&#8482;s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease.

Additionally,&#160;HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.</summary>
</bill>
